Hiding in Plain Sight: Quantifying Salbutamol and Ipratropium Inhaler Wastage in Hospitals.

The Canadian journal of hospital pharmacy Pub Date : 2023-09-01 eCollection Date: 2023-01-01 DOI:10.4212/cjhp.3405
Isla Drummond, Elissa S Y Aeng, Patrick Yeh, Christine Chen, Aaron M Tejani
{"title":"Hiding in Plain Sight: Quantifying Salbutamol and Ipratropium Inhaler Wastage in Hospitals.","authors":"Isla Drummond, Elissa S Y Aeng, Patrick Yeh, Christine Chen, Aaron M Tejani","doi":"10.4212/cjhp.3405","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous studies have found significant inhaler wastage in the inpatient setting, which contributes to unnecessary health care expenditures. Wastage may involve inhalers available in automated dispensing cabinets (ADCs).</p><p><strong>Objectives: </strong>To evaluate whether salbutamol and ipratropium inhalers were unnecessarily withdrawn from ADCs for hospital inpatients.</p><p><strong>Methods: </strong>This cross-sectional study included patients from 16 health care facilities in British Columbia. ADC reports were run for the period August 2021 to January 2022 to identify salbutamol and ipratropium inhalers removed from ADCs.</p><p><strong>Results: </strong>Over the study period, 8.3% (2180/26 324) of salbutamol and ipratropium inhalers were withdrawn from ADCs unnecessarily for the same patient encounter within a 2-day timeframe, and another 1118 (4.2%) represented instances when multiple inhalers were withdrawn for the same patient at the same time. Overall, 12.5% (3298/26 324) of all salbutamol and ipratropium inhalers were withdrawn unnecessarily. The total cost of these inhalers was about $31 600 over the 6-month period.</p><p><strong>Conclusions: </strong>This evaluation revealed considerable wastage of inhalers, leading to wasted expenditures. Other health authorities should conduct similar analyses to determine whether similar problems exist in their settings.</p>","PeriodicalId":94225,"journal":{"name":"The Canadian journal of hospital pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522357/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Canadian journal of hospital pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4212/cjhp.3405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Previous studies have found significant inhaler wastage in the inpatient setting, which contributes to unnecessary health care expenditures. Wastage may involve inhalers available in automated dispensing cabinets (ADCs).

Objectives: To evaluate whether salbutamol and ipratropium inhalers were unnecessarily withdrawn from ADCs for hospital inpatients.

Methods: This cross-sectional study included patients from 16 health care facilities in British Columbia. ADC reports were run for the period August 2021 to January 2022 to identify salbutamol and ipratropium inhalers removed from ADCs.

Results: Over the study period, 8.3% (2180/26 324) of salbutamol and ipratropium inhalers were withdrawn from ADCs unnecessarily for the same patient encounter within a 2-day timeframe, and another 1118 (4.2%) represented instances when multiple inhalers were withdrawn for the same patient at the same time. Overall, 12.5% (3298/26 324) of all salbutamol and ipratropium inhalers were withdrawn unnecessarily. The total cost of these inhalers was about $31 600 over the 6-month period.

Conclusions: This evaluation revealed considerable wastage of inhalers, leading to wasted expenditures. Other health authorities should conduct similar analyses to determine whether similar problems exist in their settings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
隐藏在众目睽睽之下:医院中沙丁胺醇和异丙托品吸入器损耗的量化。
背景:先前的研究发现,在住院环境中,吸入器浪费严重,这导致了不必要的医疗保健支出。浪费可能涉及自动分配柜(ADC)中的吸入器。目的:评估医院住院患者是否不必要地从ADC中撤出了沙丁胺醇和异丙托溴铵吸入器。方法:这项横断面研究包括来自不列颠哥伦比亚省16个医疗机构的患者。ADC在2021年8月至2022年1月期间进行了报告,以确定从ADC中移除的沙丁胺醇和异丙托溴铵吸入器,另外1118个(4.2%)代表同时为同一患者取出多个吸入器的情况。总体而言,12.5%(3298/26324)的沙丁胺醇和异丙托溴铵吸入器被不必要地停用。在6个月的时间里,这些吸入器的总成本约为31600美元。结论:这项评估显示,吸入器的浪费相当大,导致支出浪费。其他卫生当局应进行类似的分析,以确定其环境中是否存在类似的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Adverse Drug Reactions and Predictors of Medication Adherence in Patients with Prostate Cancer. Changes in Acute Care Pharmacist Prescribing and Laboratory Ordering over Time: CAPLET Study. Continuous IV Deferoxamine for Chronic Iron Overload in Patients Undergoing Hemodialysis by Home Parenteral Therapy: A Case Report and Literature Review. Efficacité de 6 scénarios de décontamination de bras de fauteuils contaminés volontairement au cyclophosphamide. Glycemic Management in Patients with COVID-19 Admitted to the Intensive Care Unit: Evaluation of Glycemic Control and Drug Therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1